DOE Agile BioFoundry Opens Industry Day for Biomanufacturing Partnerships
The Agile BioFoundry is hosting its fall 2026 Industry Day on October 26 to connect stakeholders with DOE National Labs on synthetic biology,...

Created by Christine Farley
Balanced news and deep dives on peptides, biohacking, biotech, quantum computing, and AI applications
Explore the latest content tracked by BioTech Frontier Digest
The Agile BioFoundry is hosting its fall 2026 Industry Day on October 26 to connect stakeholders with DOE National Labs on synthetic biology,...
After two decades of self-experimentation, Ben Greenfield now prioritizes hormesis practices like daily heat/cold exposure, varied plants, and...
This hub organizes senescence research into clear categories for longevity readers.
RMTG's Peptide Certification 2.0 directly ties ISSCA physician training to Cellgenic's product portfolio, revealing a deliberate education-to-sales...
Peptide enthusiasm is shifting from molecular hacks to structured consumer clinics, but oversight lags.
Can self-hosted AI agents transform a personal computer into a fully integrated coding, image, and audio production system while keeping all data...
SS-31 binds cardiolipin in the inner mitochondrial membrane, altering surface potential to improve oxidative phosphorylation coupling in stressed...
Does the 29% weight-loss result from tirzepatide plus eloralintide mark a meaningful step beyond monotherapy?
Synth generates an 80B-token corpus from 58k Wikipedia seeds to collapse pre-, mid-, and post-training into one stage, delivering higher factual...
Basic molecular-weight and dosing calculations continue to serve as critical safeguards in peptide research.
A planned industry-academic trial of Niagen (NR) will evaluate major clinical outcomes, Intrinsic Capacity measures like cognition and fatigue, and...
Question: Can oral peptide tablets improve adherence, or do they merely shift burdens to absorption variability, dosing rules, and formulation...
AI-moderated research reveals a clear gap between popular wellness trends and where consumers actually struggle.
Vitamin D and omega-3 supplements linked to faster cognitive decline in older adults with normal levels, while glucosamine associated with Alzheimer's...
The market is forecast to grow from USD 1.21 billion in 2026 to USD 2.44 billion by 2032 at 12.29% CAGR, driven by integrated AI-lab workflows.
-...
Novo's €1.17B licensing deal with Nanexa targets monthly or quarterly GLP-1 injectables via PharmaShell's atomic-layer coating to boost adherence and access, yet the pact covers upfront milestones and royalties rather than proven clinical results.